Zobrazeno 1 - 3
of 3
pro vyhledávání: '"D’Souza, Flevy"'
Autor:
Díaz-Carballo, David, Safoor, Ayesha, Saka, Sahitya, Noa-Bolaño, Adrien, D’Souza, Flevy, Klein, Jacqueline, Acikelli, Ali H., Malak, Sascha, Rahner, Udo, Turki, Amin T., Höppner, Anne, Kamitz, Annabelle, Song, Wanlu, Chen, Ye-guang, Kamada, Lalitha, Tannapfel, Andrea, Brinkmann, Sebastian, Ochsenfarth, Crista, Strumberg, Dirk
Publikováno v:
Scientific Reports; 11/26/2024, Vol. 14 Issue 1, p1-34, 34p
Autor:
Díaz-Carballo, David, Saka, Sahitya, Acikelli, Ali H., Homp, Ekaterina, Erwes, Julia, Demmig, Rebecca, Klein, Jacqueline, Schröer, Katrin, Malak, Sascha, D’Souza, Flevy, Noa-Bolaño, Adrien, Menze, Saskia, Pano, Emilio, Andrioff, Swetlana, Teipel, Marc, Dammann, Philip, Klein, Diana, Nasreen, Amber, Tannapfel, Andrea, Grandi, Nicole, Tramontano, Enzo, Ochsenfarth, Crista, Strumberg, Dirk
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-16 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-16 (2021)
In this work, we are reporting that “Shock and Kill”, a therapeutic approach designed to eliminate latent HIV from cell reservoirs, is extrapolatable to cancer therapy. This is based on the observation that malignant cells express a spectrum of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f3bb3c77951bc9eecbd9d44cc97cc07e
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85101999654
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85101999654
Autor:
Díaz-Carballo D; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany. david.diaz-carballo@marienhospital-herne.de., Saka S; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Acikelli AH; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Homp E; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Erwes J; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Demmig R; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Klein J; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Schröer K; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Malak S; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., D'Souza F; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Noa-Bolaño A; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Menze S; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Pano E; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Andrioff S; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Teipel M; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany., Dammann P; Central Animal Laboratory, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Klein D; Institute of Cell Biology, Cancer Research, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Nasreen A; Visceral Surgery Department, Marien Hospital Herne, Ruhr University Bochum Medical School, Herne, Germany., Tannapfel A; Institute of Pathology, Ruhr University Bochum, Bochum, Germany., Grandi N; Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, Monserrato, Italy., Tramontano E; Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, Monserrato, Italy., Ochsenfarth C; Department of Anesthesia, Intensive Care, Pain and Palliative Medicine, Marien Hospital Herne, Ruhr-University Bochum Medical School, Herne, Germany., Strumberg D; Ruhr University Bochum, Faculty of Medicine, Department of Haematology and Oncology, Institute of Molecular Oncology and Experimental Therapeutics, Marien Hospital Herne, Herne, Germany.
Publikováno v:
Communications biology [Commun Biol] 2021 Mar 03; Vol. 4 (1), pp. 276. Date of Electronic Publication: 2021 Mar 03.